These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 8615640)
1. Antitumor effect of carboplatin combined with hyperthermia on Ehrlich-ascites tumor in vivo. Mizuuchi H; Yoshiga K; Sakurai K; Tsumura M; Takada K Anticancer Res; 1996; 16(1):381-7. PubMed ID: 8615640 [TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of carboplatin combined with radiation on tumors in mice. Aratani Y; Yoshiga K; Mizuuchi H; Jo A; Tanimoto K; Sakurai K Anticancer Res; 1997; 17(4A):2535-8. PubMed ID: 9252676 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of antitumor effects of new analogue of platinum, cis-diammine (glycolato) platinum (254-S) combined with hyperthermia in vivo. Jo A; Sakurai K; Tsumura M; Mizuuchi H; Yoshiga K; Takada K Anticancer Res; 1996; 16(1):301-4. PubMed ID: 8615625 [TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice. Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181 [TBL] [Abstract][Full Text] [Related]
5. Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model. Chang MJ; Yu WD; Reyno LM; Modzelewski RA; Egorin MJ; Erkmen K; Vlock DR; Furmanski P; Johnson CS Cancer Res; 1994 Oct; 54(20):5380-6. PubMed ID: 7923169 [TBL] [Abstract][Full Text] [Related]
6. Increased therapeutic efficacy induced by tumor necrosis factor alpha combined with platinum complexes and whole-body hyperthermia in rats. Ohno S; Strebel FR; Stephens LC; Siddik ZH; Makino M; Klostergaard J; Tomasovic SP; Khokhar AR; Bull JM Cancer Res; 1992 Aug; 52(15):4096-101. PubMed ID: 1638521 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of cytotoxic and antitumor effects of a tetravalent analog of carboplatin. Jurásková V; Brabec V Neoplasma; 1989; 36(3):297-303. PubMed ID: 2739808 [TBL] [Abstract][Full Text] [Related]
8. [Combined effects of local hyperthermia, bleomycin, and x-ray on Ehrlich ascites tumor in mice]. Kai H Nihon Geka Gakkai Zasshi; 1985 Aug; 86(8):901-11. PubMed ID: 2414640 [TBL] [Abstract][Full Text] [Related]
9. Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats. Ohno S; Siddik ZH; Baba H; Stephens LC; Strebel FR; Wondergem J; Khokhar AR; Bull JM Cancer Res; 1991 Jun; 51(11):2994-3000. PubMed ID: 2032236 [TBL] [Abstract][Full Text] [Related]
10. Influence of 5-hydroxytryptamine on the combination effect of lonidamine or gossypol and hyperthermia on Ehrlich tumour in vivo. Molla MR; Yoshiga K; Takada K Anticancer Res; 1987; 7(3 Pt B):361-4. PubMed ID: 3631888 [TBL] [Abstract][Full Text] [Related]
11. [Antitumor activity of a new platinum complex (R)-(-)-2-aminomethylpyrrolidine (1,1-cyclobutane dicarboxylato) platinum (II) (DWA2114R) by its serial administration]. Akamatsu K; Endo K; Matsumoto T; Kamisango K; Morikawa K; Koizumi M; Mitsui H; Koizumi K; Matsuno T Gan To Kagaku Ryoho; 1989 May; 16(5):2039-43. PubMed ID: 2658840 [TBL] [Abstract][Full Text] [Related]
12. [Effect of treatment schedule of an antitumor platinum complex, DWA2114R, on the antitumor activity]. Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K Gan To Kagaku Ryoho; 1992 Feb; 19(2):223-8. PubMed ID: 1736834 [TBL] [Abstract][Full Text] [Related]
13. Optimal duration of whole body hyperthermia when combined with cis-diaminne-1,1-cychlobutane dicarboxylate platinum (II) (carboplatin). Kaneko T; Sakaguchi Y; Makino M; Matsuda H; Strebel FR; Jenkins GN; Bull JM Anticancer Res; 1997; 17(3C):1897-901. PubMed ID: 9216642 [TBL] [Abstract][Full Text] [Related]
14. Direct antitumor effect of cepharanthin and combined effect with adriamycin against Ehrlich ascites tumor in mice. Asaumi J; Nishikawa K; Matsuoka H; Iwata M; Kawasaki S; Hiraki Y; Nishijima K Anticancer Res; 1995; 15(1):67-70. PubMed ID: 7733643 [TBL] [Abstract][Full Text] [Related]
15. On the possible use of a new boron compound, hydroxysalicylhydroxamato boron(III), and ultrasound in the treatment of female mice bearing the Ehrlich ascites carcinoma cells. Ghosh P; Sur P; Bag SP; Sur B; Chatterjee SN Neoplasma; 1998; 45(6):384-8. PubMed ID: 10210114 [TBL] [Abstract][Full Text] [Related]
16. [Basic and clinical investigations of the effectiveness of hyperthermia combined with chemotherapy and irradiation in the treatment in patients with esophageal carcinoma]. Kuwano H; Sugimachi K Kyobu Geka; 1989 Jul; 42(8 Suppl):677-81. PubMed ID: 2481761 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of cytogenetic damage and of antineoplastic effect by caffeine in Ehrlich ascites tumor cells treated with cyclophosphamide in vivo. Mourelatos D; Dozi-Vassiliades J; Kotsis A; Gourtsas C Cancer Res; 1988 Mar; 48(5):1129-31. PubMed ID: 3342394 [TBL] [Abstract][Full Text] [Related]
18. In vitro efficacy of carboplatin and hyperthermia in a murine retinoblastoma cell line. Murray TG; Cicciarelli N; McCabe CM; Ksander B; Feuer W; Schiffman J; Mieler WF; O'Brien JM Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2516-22. PubMed ID: 9375570 [TBL] [Abstract][Full Text] [Related]
19. Interactions of thymidine, hyperthermia, and cis-diammine-1,1-cyclobutane dicarboxylate platinum (II) in human T-cell leukemia. Cohen JD; Robins HI; Schmitt CL; Tanner MA Cancer Res; 1989 Nov; 49(21):5805-9. PubMed ID: 2676150 [TBL] [Abstract][Full Text] [Related]
20. Hyperthermic enhancement of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) cytotoxicity in human leukemia cells in vitro. Cohen JD; Robins HI Cancer Res; 1987 Aug; 47(16):4335-7. PubMed ID: 3300964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]